About Cooley Godward Kronish LLP

We are the market leader with over 25 years of dedicated service in helping our clients build the life sciences industry. Our experienced teams are highly integrated, business oriented and comprehensive in approach. We have represented nearly 30 percent of the companies on the NASDAQ Biotechnology and BioCentury 100TM Indices and more than half of the companies on the AMEX Biotech Index. Today, we represent over 500 life sciences companies, both public and private, here in the U.S. and internationally, in nearly all aspects of their business. Our deep domain expertise also enables us to effectively and efficiently represent many venture capital clients in their investments in life sciences companies, as well as lending institutions and investment banks servicing those companies.

One of the key differentiators of our Life Science practice is our great depth and experience in Corporate Partnering & Licensing transactions. From the earliest R&D clinical limited partnerships to the latest ground-breaking collaborations, Cooley's Life Sciences attorneys have helped structure and negotiate many of the most innovative deal strategies in the industry. We have particular expertise in "cross-over" matters involving bioinformatic and other IT-implemented inventions.

Our attorneys have deep expertise across all aspects of life sciences technologies, including:

• Genomics
• Proteomics
• Drug discovery tools
• Vaccines
• Screening assays and methods
• Biological and small organic therapeutic compounds and uses

For more information, visit the Cooley website here.